What's new?

 

Welcome to
US Medical Affairs

Chronic Kidney Disease

Welcome to Bayer's Medical Affairs Chronic Kidney Disease (CKD) platform.

 

CKD is one of the most frequent complications arising from diabetes and is an independent risk factor of cardiovascular disease. CKD associated with type 2 diabetes (T2D) is the most common cause of kidney failure worldwide.

 

With early intervention being associated with a better prognosis for these patients, at Bayer, we are committed to advancing awareness, knowledge, and therapeutic options for CKD associated with T2D. We invite you to explore educational resources and information on this website.

Recent Updates

November 2024

Publications Added

Take me there!

November 2024

ASN Congress Presentations

Take me there!

November 2024

Publications Added

November 2024

ASN Congress Presentations